Drug trial aims to make labor shorter and safer

NCT ID NCT07237880

Recruiting now Symptom relief Sponsor: Hillel Yaffe Medical Center Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a medication called papaverine can safely shorten the time it takes to give birth after labor is induced. Pregnant women who have a balloon catheter placed to help start labor will receive either the drug or a placebo (saltwater) after the catheter is removed. Researchers will measure how long labor lasts and check for any effects on the mother or baby.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LABOR, INDUCED are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hillel Yaffe Medical Center
RECRUITING

Hadera, Israel

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LABOR, INDUCED